DXR Financial Facts

Total Cost of Sales: 149.38K
Cost of cryobanking and related services: 13.21K
See Full Income Statement

Total Liabilities and Stockholders’ Equity: 85.72M
Retained earnings: 24.74M
See Full Balance Sheet

Daxor Corp. (DXR) Earnings

  |   Expand Research on DXR
Next EPS Date 11/12/26 EPS Growth Rate N/A
Average EPS % Beat Rate N/A Revenue Growth Rate N/A
Average % Move 1-Wk after EPS N/A Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/12/26 Q326 N/A-$0.03 N/A N/A$3.2M N/A N/A N/A
8/24/26 Q226 N/A-$0.03 N/A N/A$2.8M N/A N/A N/A
8/20/26 Q226 N/A-$0.03 N/A N/A$2.8M N/A N/A N/A
8/31/26 Q226 N/A-$0.03 N/A N/A$2.8M N/A N/A N/A
8/25/26 Q226 N/A-$0.03 N/A N/A$2.8M N/A N/A N/A
8/27/26 Q226 N/A-$0.03 N/A N/A$2.8M N/A N/A N/A
8/29/25 Q225 N/AN/A N/A N/AN/A N/A N/A N/A
5/13/25 Q125 N/AN/A N/A N/AN/A N/A N/A N/A